Oral Oncology
Volume 46, Issue 1 , Pages 25-30 , January 2010

Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients

  • Paula Cristina Batista Faria

      Affiliations

    • Nanobiotechnology Laboratory, Institute of Genetics and Biochemistry, Federal University of Uberlândia, Av. Amazonas, Bloco 2E, Campus Umuarama, CEP 38400-902 Uberlândia, MG, Brazil
    • Theses authors contributed equally to this work.
    • ,
  • Angela Aparecida Servino Sena

      Affiliations

    • Nanobiotechnology Laboratory, Institute of Genetics and Biochemistry, Federal University of Uberlândia, Av. Amazonas, Bloco 2E, Campus Umuarama, CEP 38400-902 Uberlândia, MG, Brazil
    • Theses authors contributed equally to this work.
    • ,
  • Rafael Nascimento

      Affiliations

    • Nanobiotechnology Laboratory, Institute of Genetics and Biochemistry, Federal University of Uberlândia, Av. Amazonas, Bloco 2E, Campus Umuarama, CEP 38400-902 Uberlândia, MG, Brazil
    • ,
  • Washington João Carvalho

      Affiliations

    • Nanobiotechnology Laboratory, Institute of Genetics and Biochemistry, Federal University of Uberlândia, Av. Amazonas, Bloco 2E, Campus Umuarama, CEP 38400-902 Uberlândia, MG, Brazil
    • ,
  • Adriano Mota Loyola

      Affiliations

    • Oral Pathology Laboratory, Clinics’ Hospital, Federal University of Uberlândia, MG, Brazil
    • ,
  • Sindeval José Silva

      Affiliations

    • Head and Neck Service, Clinics’ Hospital, Federal University of Uberlândia, MG, Brazil
    • ,
  • Antônio Francisco Durighetto Junior

      Affiliations

    • Stomatology Diagnosis Unit, Faculty of Dentistry, Federal University of Uberlândia, MG, Brazil
    • ,
  • Anísio Domingos Oliveira Junior

      Affiliations

    • Stomatology Diagnosis Unit, Faculty of Dentistry, Federal University of Uberlândia, MG, Brazil
    • ,
  • Sonia Maria Oliani

      Affiliations

    • Immunomorphology Laboratory, Department of Biology, Instituto de Biociências, Letras e Ciências Exatas (IBILCE), UNESP, Av. Cristóvão Colombo, 2265, CEP 15054-000 São José do Rio Preto, SP, Brazil
    • Corresponding Author InformationCorresponding authors. Tel.: +55 34 32182478, fax: +55 34 32182203 (L.R. Goulart), tel.: +55 17 32212381 (S.M. Oliani).
    • The last two authors are considered as senior authors.
    • ,
  • Luiz Ricardo Goulart

      Affiliations

    • Nanobiotechnology Laboratory, Institute of Genetics and Biochemistry, Federal University of Uberlândia, Av. Amazonas, Bloco 2E, Campus Umuarama, CEP 38400-902 Uberlândia, MG, Brazil
    • Corresponding Author InformationCorresponding authors. Tel.: +55 34 32182478, fax: +55 34 32182203 (L.R. Goulart), tel.: +55 17 32212381 (S.M. Oliani).
    • The last two authors are considered as senior authors.

Received 29 July 2009 ,Revised 7 September 2009 ,Accepted 7 September 2009.

References 

  1. Khanna SS, Karjodkar FR. Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med. 2006;2:33
  2. Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, Wei KJ, et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med. 2009;38(4):362–370
  3. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009;45(8):731–736
  4. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45(4–5):301–308
  5. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009. in press.
  6. Hassan NM, Tada M, Hamada J, Kashiwazaki H, Kameyama T, Akhter R, et al. Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Lett. 2008;270(1):108–119
  7. Vishwanatha JK, Swinney R, Banerjee AG. Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. Mol Cell Biochem. 2003;248(1–2):67–75
  8. Perretti M, Flower RJ. Annexin 1 and the biology of the neutrophil. J Leukoc Biol. 2004;76(1):25–29
  9. Kamal AM, Flower RJ, Perretti M. An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem Inst Oswaldo Cruz. 2005;100(1):39–48
  10. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 2007;21(4):968–975
  11. Perretti M, D’Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1):62–70
  12. Kang JS, Calvo BF, Maygarden SJ, Caskey LS, Mohler JL, Ornstein DK. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res. 2002;8(1):117–123
  13. Hayes MJ, Moss SE. Annexins and disease. Biochem Biophys Res Commun. 2004;322(4):1166–1170
  14. Sena AA, Provazzi PJ, Fernandes AM, Cury PM, Rahal P, Oliani SM. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis. Clin Exp Allergy. 2006;36(10):1260–1267
  15. Sawmynaden P, Perretti M. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem Biophys Res Commun. 2006;349(4):1351–1355
  16. Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, Maniglia JV, Raposo LS, Tajara EH, et al. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer. 2007;120(12):2582–2589
  17. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol. 2006;24(11):1754–1760
  18. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science. 1997;278(5340):1054–1059
  19. Sobin LH, Wittekind CH. International union against cancer (UICC) TNM classification of malignant tumours. 6th ed.. Wiley: New York; 2002;p. 22–6
  20. Barnes L, Everson JW, Reichart P. World health organisation classification of tumours pathology and genetics of head and neck tumours. JARC Press: Lyon; 2005;p. 168–175
  21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162(1):156–159
  22. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol. 1995;76(2):195–202
  23. D’Acquisto F, Merghani A, Lecona E, Rosignoli G, Raza K, Buckley CD, et al. Annexin-1 modulates T-cell activation and differentiation. Blood. 2007;109(3):1095–1102
  24. Rondepierre F, Bouchon B, Papon J, Bonnet-Duquennoy M, Kintossou R, Moins N, et al. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta. 2009;1794(1):61–69
  25. Goldenberg D, Brooksby C, Hollenbeak CS. Age as a determinant of outcomes for patients with oral cancer. Oral Oncol. 2009;45(8):e57–e61
  26. Papageorge M. Etiology of oral cancer in the young patient: is tongue cancer becoming the other cancer in women?. Oral Maxillofac Surg Clin North Am. 2007;19(2):163–171
  27. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194–200
  28. Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate. 2006;66(13):1413–1424
  29. Alldridge LC, Bryant CE. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res. 2003;290(1):93–107
  30. Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003;4(4):587–598
  31. Scannell M, Flanagan MB, de Stefani A, Wynne KJ, Cagney G, Godson C, et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol. 2007;178(7):4595–4605
  32. Besse F, Ephrussi A. Translational control of localized mRNAs: restricting protein synthesis in space and time. Nat Rev Mol Cell Biol. 2008;9(12):971–980

PII: S1368-8375(09)00912-9

doi: 10.1016/j.oraloncology.2009.09.003

Oral Oncology
Volume 46, Issue 1 , Pages 25-30 , January 2010

Article Tools

* Image Usage & Resolution